Secukinumab Subcutaneous and Tapentadol Extended-Release Tablets
Determining the interaction of Secukinumab Subcutaneous and Tapentadol Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: secukinumab
Brand name: Cosentyx, Cosentyx Sensoready Pen
Synonyms: Secukinumab
Generic Name: tapentadol
Brand name: Nucynta, Nucynta ER
Synonyms: Tapentadol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Secukinumab Subcutaneous-Tapentadol Hydrochloride
- Secukinumab Subcutaneous-Tapentadol Tablets
- Secukinumab Subcutaneous-TaperDex 12-day
- Secukinumab Subcutaneous-TaperDex 6-day
- Secukinumab Subcutaneous-TaperDex 7-day
- Secukinumab Subcutaneous-Tar Distillate Topical
- Tapentadol Extended-Release Tablets-Secura Antifungal
- Tapentadol Extended-Release Tablets-Secura Antifungal Extra Thick
- Tapentadol Extended-Release Tablets-Secura Antifungal Topical
- Tapentadol Extended-Release Tablets-Seebri
- Tapentadol Extended-Release Tablets-Seebri Neohaler
- Tapentadol Extended-Release Tablets-Seebri Neohaler inhalation